Your browser doesn't support javascript.
loading
High-Throughput, Fluorescence-Based Esterase Activity Assay for Assessing Polysorbate Degradation Risk during Biopharmaceutical Development.
Bhargava, Adithi C; Mains, Kathryn; Siu, Albert; Gu, Jie; Zarzar, Jonathan; Yi, Li; Yuk, Inn H.
Afiliación
  • Bhargava AC; Pharmaceutical Development, Genentech Inc., 1 DNA Way, MS 562a, South San Francisco, CA, 94080, USA. chandrasekhara.adithi@gene.com.
  • Mains K; Pharmaceutical Development, Genentech Inc., 1 DNA Way, MS 562a, South San Francisco, CA, 94080, USA.
  • Siu A; Department of Chemical and Biological Engineering, University of Colorado, Boulder, 3415 Colorado Ave, Boulder, CO, 80303, USA.
  • Gu J; Pharmaceutical Development, Genentech Inc., 1 DNA Way, MS 562a, South San Francisco, CA, 94080, USA.
  • Zarzar J; Pharmaceutical Development, Genentech Inc., 1 DNA Way, MS 562a, South San Francisco, CA, 94080, USA.
  • Yi L; Pharmaceutical Development, AbbVie Inc., 1500 Seaport Blvd, Redwood City, CA, 94065, USA.
  • Yuk IH; Pharmaceutical Development, Genentech Inc., 1 DNA Way, MS 562a, South San Francisco, CA, 94080, USA.
Pharm Res ; 38(3): 397-413, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33655394
ABSTRACT

PURPOSE:

Hydrolytic degradation of polysorbate during 2-8°C storage of monoclonal antibody drug products has been attributed to residual enzymes (e.g., esterases) from bioprocessing steps. Robust detection of esterase activity using sensitive, non-polysorbate surrogate substrates can provide an alternate method to assess polysorbate degradation risk, if the correlation between the esterase activity and polysorbate degradation is established.

METHODS:

A general esterase activity assay was developed as a monitoring and characterization tool during bioprocess development of monoclonal antibodies.

RESULTS:

We report a fluorescence plate-based assay for quantifying esterase activity, utilizing 4-methylumbelliferyl caprylate (MU-C8) as the esterase substrate. The assay was first assessed for substrate, inhibitor and pH specificity using both model enzymes and purified protein samples. The assay was then extensively tested to understand sample matrix effects on activity rates.

CONCLUSIONS:

The use of this high-throughput method will allow for rapid characterization of protein samples in under three hours. The esterase activity correlated directly with polysorbate degradation and can provide valuable information on polysorbate degradation risk throughout drug development.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisorbatos / Esterasas Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Pharm Res Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisorbatos / Esterasas Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Pharm Res Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos